TREATMENT WITH DECITABINE (DAC) INDUCES THE EXPRESSION OF STEMNESS MARKERS, PD-L1 AND NY-ESO-1 IN COLORECTAL CANCER

被引：0
|
作者：
Taib, Nassiba [1 ]
Merhi, Maysaloun [1 ]
Inchakalody, Varghese [1 ]
Mestiri, Sarra [1 ]
Raza, Afsheen [1 ]
Uddin, Shahab [1 ]
Maccalli, Cristina [2 ]
AlHomsi, Mohammed Ussama [1 ]
Dermime, Said [1 ]
机构：
[1] Hamad Med Corp, Doha, Qatar
[2] Sidra Med, Doha, Qatar
来源：
JOURNAL FOR IMMUNOTHERAPY OF CANCER | 2021年 / 9卷
关键词：
D O I：
10.1136/jitc-2021-SITC2021.736
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
736
引用
收藏
页码：A767 / A767
页数：1
相关论文
共 50 条
  • [41] NY-ESO-1 expression in sarcomas A diagnostic marker and immunotherapy target
    Lai, Jin-Ping
    Rosenberg, Avi Z.
    Miettinen, Markku M.
    Lee, Chyi-Chia R.
    ONCOIMMUNOLOGY, 2012, 1 (08): : 1409 - 1410
  • [42] Expression of MAGE-A and NY-ESO-1 in Primary and Metastatic Cancers
    Park, Tristen S.
    Groh, Eric M.
    Patel, Krishna
    Kerkar, Sid P.
    Lee, Chyi-Chia Richard
    Rosenberg, Steven A.
    JOURNAL OF IMMUNOTHERAPY, 2016, 39 (01) : 1 - 7
  • [43] NY-ESO-1 expression is associated with primary cutaneous melanoma thickness
    Bianchi, Mara Giavina
    Festa Neto, Cyro
    Duncan, Lyn
    Sotto, Miriam
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2014, 70 (05) : AB74 - AB74
  • [44] NY-ESO-1 protein glycosylated by yeast induces enhanced immune responses
    Wadle, Andreas
    Mischo, Axel
    Strahl, Sabine
    Nishikawa, Hiroyoshi
    Held, Gerhard
    Neumann, Frank
    Wullner, Beate
    Fischer, Eliane
    Kleber, Sascha
    Karbach, Julia
    Jager, Elke
    Shiku, Hiroshi
    Odunsi, Kunle
    Shrikant, Protul A.
    Knuth, Alexander
    Cerundolo, Vincenzo
    Renner, Christoph
    YEAST, 2010, 27 (11) : 919 - 931
  • [45] NY-ESO-1 EXPRESSION IN MALIGNANT MELANOMA: A TARGET MARKER FOR IMMUNOTHERAPY
    Liu, Y.
    Robbins, P.
    Rosenberg, S.
    Lee, C.
    JOURNAL OF CUTANEOUS PATHOLOGY, 2011, 38 (01) : 90 - 91
  • [46] ADOPTIVE TRANSFER IMMUNOTHERAPY TARGETING NY-ESO-1 FOR TREATMENT OF GLIOBLASTOMA
    Everson, Richard G.
    Lisiero, Dominique N.
    Soto, Horacio
    Liau, Linda M.
    Prins, Robert M.
    NEURO-ONCOLOGY, 2012, 14 : 41 - 42
  • [47] NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors
    Sugita, Y
    Wada, H
    Fujita, S
    Nakata, T
    Sato, S
    Noguchi, Y
    Jungbluth, AA
    Yamaguchi, M
    Chen, YT
    Stockert, E
    Gnjatic, S
    Williamson, B
    Scanlan, MJ
    Ono, T
    Sakita, I
    Yasui, M
    Miyoshi, Y
    Tamaki, Y
    Matsuura, N
    Noguchi, S
    Old, LJ
    Nakayama, E
    Monden, M
    CANCER RESEARCH, 2004, 64 (06) : 2199 - 2204
  • [48] Expression and Purification of cGMP grade NY-ESO-1 for Clinical Trials
    Lowe, Adam J.
    Bardliving, Cameron L.
    Huang, Chung-Jr
    Teixeira, Leonardo M.
    Damasceno, Leonardo M.
    Anderson, Kyle A.
    Ritter, Gerd
    Old, Lloyd J.
    Batt, Carl A.
    BIOTECHNOLOGY PROGRESS, 2011, 27 (02) : 435 - 441
  • [49] Toward the Total Chemical Synthesis of the Cancer Protein NY-ESO-1
    Harris, Paul W. R.
    Brimble, Margaret A.
    BIOPOLYMERS, 2010, 94 (04) : 542 - 550
  • [50] Evidence of immunoediting in NY-ESO-1/ISCOMATRIX cancer vaccination recipients
    Chew, S
    Kanaan, C
    Browning, J
    MacGregor, D
    Davis, I
    Cebon, J
    Tait, BD
    TISSUE ANTIGENS, 2005, 66 (05): : 378 - 378
12345